Effect of monthly intravenous ibandronate injections on vertebral or non-vertebral fracture risk in Japanese patients with high-risk osteoporosis in the MOVER study

Effect of monthly intravenous ibandronate injections on vertebral or non-vertebral fracture risk in Japanese patients with high-risk osteoporosis in the MOVER study

We examined the efficacy of intravenous (IV) ibandronate 1 mg/month in patient subgroups in the phase III MOVER study. Here we present results of analyses on the incidence of fractures in patients with prevalent vertebral fractures (1 or ≥2, and ≥3) at screening and femoral neck (FN) bone mineral de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of bone and mineral metabolism 2017, Vol.35 (1), p.58-64
Hauptverfasser: Ito, Masako, Tobinai, Masato, Yoshida, Seitaro, Hashimoto, Junko, Nakamura, Toshitaka
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Aged, 80 and over
Asian Continental Ancestry Group
Bone Density - drug effects
Diphosphonates - administration & dosage
Female
Femoral Neck Fractures - epidemiology
Femoral Neck Fractures - etiology
Femoral Neck Fractures - metabolism
Femoral Neck Fractures - prevention & control
Femur Neck - metabolism
Humans
Japan - epidemiology
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Middle Aged
Original Article
Orthopedics
Osteoporosis - complications
Osteoporosis - drug therapy
Osteoporosis - epidemiology
Osteoporosis - metabolism
Risedronate Sodium - administration & dosage
Spinal Fractures - epidemiology
Spinal Fractures - etiology
Spinal Fractures - metabolism
Spinal Fractures - prevention & control
Spine - metabolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We examined the efficacy of intravenous (IV) ibandronate 1 mg/month in patient subgroups in the phase III MOVER study. Here we present results of analyses on the incidence of fractures in patients with prevalent vertebral fractures (1 or ≥2, and ≥3) at screening and femoral neck (FN) bone mineral density (BMD) T scores ≥−2.5 or 
ISSN:0914-8779
1435-5604
DOI:10.1007/s00774-015-0723-x